Clonidin-Carinopharm 0.15 mg/ml
Hypertension, Sedation in ICU
ApprovedActive
Key Facts
About Carinopharm
Carinopharm is a commercial-stage, private pharmaceutical company based in Germany, specializing in hospital-based injectable therapies for acute care. Founded in 2015, it has established a commercial portfolio of small molecule drugs, including branded generics and some proprietary products, targeting cardiology and intensive/emergency care. The company operates a straightforward business model of development, manufacturing (via partners), and distribution of niche, essential medicines primarily to the German hospital market. Its outlook is tied to maintaining a reliable supply of critical care drugs and selectively expanding its portfolio.
View full company profileTherapeutic Areas
Other Hypertension, Sedation in ICU Drugs
| Drug | Company | Phase |
|---|---|---|
| Alcaridin (Clonidin) 0.15 mg/ml | Carinopharm | Approved |